Израел - Енглески - Ministry of Health

sanofi israel ltd - zopiclone - film coated tablets - zopiclone 7.5 mg - zopiclone - zopiclone - imovane is indicated for the short-term treatment of insomnia in adults

Израел - Енглески - Ministry of Health

neurim pharmaceuticals (1991) ltd, israel - melatonin - tablets prolonged release - melatonin 2 mg - melatonin - melatonin - short-term treatment for primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Европска Унија - Енглески - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders - psycholeptics - circadin is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

generic partners pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: magnesium stearate; purified talc; colloidal anhydrous silica; calcium hydrogen phosphate dihydrate; lactose monohydrate; ammonio methacrylate copolymer - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

generic partners pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - zopiclone, quantity: 7.5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; purified talc; povidone; maize starch; sodium starch glycollate type a; hypromellose; lactose monohydrate; titanium dioxide; calcium hydrogen phosphate dihydrate; macrogol 6000 - short term treatment of insomnia 7 - 14 days.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - zopiclone, quantity: 7.5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; purified talc; povidone; maize starch; sodium starch glycollate type a; hypromellose; lactose monohydrate; titanium dioxide; calcium hydrogen phosphate dihydrate; macrogol 6000 - short term treatment of insomnia (7 - 14 days)

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - zopiclone, quantity: 7.5 mg - tablet, film coated - excipient ingredients: maize starch; purified talc; sodium starch glycollate type a; colloidal anhydrous silica; magnesium stearate; povidone; titanium dioxide; hypromellose; lactose monohydrate; macrogol 6000; calcium hydrogen phosphate dihydrate - short term treatment of insomnia (7 -14 days)

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - zopiclone, quantity: 7.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; titanium dioxide; macrogol 6000; lactose monohydrate; calcium hydrogen phosphate dihydrate; wheat starch; sodium starch glycollate; hypromellose - the short-term treatment of insomnia (7 to 14 days).